Recombinant Protein Targets that are commonly used for CAR discovery and development.A variety of tags and fluorescent labels are available for you to discover!

The universal CAR detection tool is FACS validated for highly specific and sensitive binding to CAR cells with broad applicability. It provides comprehensive support throughout the development process of cell therapy drugs.

Looking for recombinant MHC proteins? Our MHC proteins come in either monomeric or tetrameric forms and are expressed using our HEK293 platform to ensure the structure is as close to its native structure as possible!

Neurological disorders such as Alzheimers are driven by mutagenic proteins that aggregate and cause neural cell death. Explore our products to assist your research into neuroscience and discover new drug targets to combat neurodegenerative diseases.

The interaction between Streptavidin and biotin is one of the most commonly utilized interactions in biology for screening, purification, and assay development.

In the early stages of biopharmaceutical development, it is crucial to provide highly sensitive, specific, and validated immunoassay products for cytokines and biomarkers. These assays enable quantitative detection of target analytes across various species, facilitating the verification of drug mechanisms and efficacy evaluations.

Immunohistochemistry (IHC) is an antibody-based technique used for the localization, qualitative, and quantitative analysis of antigens within tissue cells. It is widely applied in medical research, biological detection, and pathological diagnosis.

Strictly following the GMP quality system, we provide multiple GMP grade cytokines to support the large-scale manufacturing and differentiation of immune cells, stem cells, and other cell types.

Specially designed to support the large-scale manufacturing needs of stem cells (iPSC/ESC/MSC, etc.), rigorously tested to ensure compliance with the highest standards, providing excellent performance for stem cell research and drug development.

Provide culture media suitable for various types of cell cultures such as T cells, NK cells, CAR-T, CIK, CAR-NK, etc; Chemically defined, no serum, animal origin-free, higher expansion efficiency!

A series of tools for cell activation, such as classical antibodies, magnetic beads, and specific antigen coupled magnetic beads, have been validated at the cellular level and can efficiently stimulate and expand target cells, better assisting the development process of cell therapy drugs.

Gene editing technology is widely used in gene therapy and CAR cell therapy, typically using delivery systems such as viral vectors to deliver specific genetic material into specific target cells, modifying the expression of individual genes or repairing abnormal genes. We focus on the CGT field and provide high-quality gene editing related tools.

Sample cleanup is a necessary part of manufacturing designed to prepare the final therapeutic for patient safety and successful IND application. Explore our nucleases designed to remove nucleic acid residues.

Our various solutions aim to provide customers with a more comprehensive and high-quality service experience, and accelerate the commercialization of CGT drugs!

We have an experienced Custom GMP-grade Products team and a high standard GMP factory, which can provide you with strong support. It has advantages such as compliance with regulatory requirements, audit-friendly, high customization and flexible adaptation capabilities, and strong application development support.

The GMP-Resilient Supply aims to provide global customers with more flexible, resilient, low-risk, high-quality, and professionally supported solutions, accelerating the development and launch process of CGT biopharmaceuticals.

Star Staining fluorescent-labeled products are developed by a new-generation site-specific labeling technology with "Star Standard" quality at ACROBiosystems. These products are uniquely designed to fully meet diverse quality control needs for CAR-positive rate detection.

We are dedicated to developing a series of anti-Linker antibodies, such as G4S Linker and Whitlow/218 Linker, covering various fluorescent labels including PE, APC, and Alexa Fluor™, providing groundbreaking solutions for CAR molecule characterization and functional testing. Additionally, we offer premium-grade anti-Linker antibodies and magnetic beads, ideal for key applications like cell activation and sorting.

Based on pharmacopeial standards and international regulations, we develop endotoxin, mycoplasma, and sterility test kits for biopharmaceutical quality control, providing comprehensive safety testing solutions.

Manufacturing biologics is a complex process that can introduce a wide variety of residues that can compromise the safety of the final therapeutic. Use our kits to detect for residues and ensure that your therapy is ready for the clinical stage.

Leveraging our flow cytometry analysis platform, we are dedicated to providing precise drug characterization and activity analysis solutions to advance drug quality control and clinical evaluation.

We provide high-quality fluorescent-labeled proteins for precise antibody density quantification on Ab-LNPs, supporting the development of in vivo CAR-T cell therapies.

The ELISA Kit is a ready-to-use immunoassay kit, validated with biological samples. We offer quantitative kits for various targets, including cytokines and biomarkers, ensuring accurate, specific, and reliable results.

Analysis and evaluation at the cellular level is one of the important indicators for evaluating drug effectiveness in vitro and is widely used in the process of new drug development.

Pharmacokinetics is a major component of evaluating drug efficacy throughout cell-based or animal models. For cell therapies, PK assays are desigend to evaluate the presence of CAR cells post-therapeutic delivery.

Pharmacodynamics is complementary to pharmacokinetics, which observes the mechanism of action of each therapy. We offer a wide variety of cell-based models and other life science tools to accelerate your PD studies.

Even CAR cells are immunogenic, despite its patient-derived origins. Evaluating the immunogenicity of any therapeutic is critical in ensuring safety.

A big side effect of CAR therapies is cytokine release syndrome. Ensuring that the therapy is not toxic is a priority to any therapy during the preclinical and clinical stages.

Immunohistochemistry (IHC) is an antibody-based technique used for the localization, qualitative, and quantitative analysis of antigens within tissue cells. It is widely applied in medical research, biological detection, and pathological diagnosis.

Pharmacokinetics is a major component of evaluating drug efficacy throughout cell-based or animal models. For cell therapies, PK assays are desigend to evaluate the presence of CAR cells post-therapeutic delivery.

In clinical research, biomarker analysis plays a pivotal role in exploratory studies, internal decision-making, and serving as clinical endpoints. We offer both traditional and novel biomarker detection kits to support clinical phase experiments. Our product range encompasses a variety of biomarkers to meet diverse research needs.

A big side effect of CAR therapies is cytokine release syndrome. Ensuring that the therapy is not toxic is a priority to any therapy during the preclinical and clinical stages.

Even CAR cells are immunogenic, despite its patient-derived origins. Evaluating the immunogenicity of any therapeutic is critical in ensuring safety.

Immunohistochemistry (IHC) is an antibody-based technique used for the localization, qualitative, and quantitative analysis of antigens within tissue cells. It is widely applied in medical research, biological detection, and pathological diagnosis.